AI Assistance May Boost Accuracy of HER2-Low Scoring for Breast Cancers

(MedPage Today) — CHICAGO — Artificial intelligence (AI) assistance appeared to enhance pathologists’ accuracy in identifying HER2-low or -ultralow expression in breast cancer tissue, a global study showed, which could cut down on missed opportunities…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115724

Author :

Publish date : 2025-05-22 21:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

AI Assistance May Boost Accuracy of HER2-Low Scoring for Breast Cancers

Mismatch Between Alzheimer’s Biomarkers and Symptoms May Signal Multiple Pathologies

FDA Approves Roflumilast Foam for Scalp, Body Psoriasis

Related Posts

Insufficient Sleep and Late Bedtimes: Early Puberty Risk?

Cannabis Use Disorder Tied to Benign Salivary Tumors

FDA Approves of VIZZ Eye Drops to Treat Presbyopia

Add-On Lobeglitazone Boosts Glycemic Control in T2D

NHS England told to keep patients in Powys waiting for operations

Atropine Drops for Vitreous Floaters Show Promise as Less Invasive Alternative

Insufficient Sleep and Late Bedtimes: Early Puberty Risk?

Cannabis Use Disorder Tied to Benign Salivary Tumors

FDA Approves of VIZZ Eye Drops to Treat Presbyopia

Add-On Lobeglitazone Boosts Glycemic Control in T2D

NHS England told to keep patients in Powys waiting for operations

Atropine Drops for Vitreous Floaters Show Promise as Less Invasive Alternative

‘I Can’t Pee Like I Used to Pee’: What We Heard This Week

Subcutaneous Lecanemab Maintenance Dosing for Alzheimer’s Supported by New Data

Categories

Archives